Akari Therapeutics (AKTX) Stock Chart & Stock Price History → The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad) Free AKTX Stock Alerts $1.47 -0.23 (-13.53%) (As of 05/2/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Akari Therapeutics Stock Price Performance5 Day Performance+24.05%1 Month Performance-2.65%3 Month Performance-40.96%6 Month Performance-60.16%Year-To-Date Performance-52.88%1 Year Performance-59.73% Receive AKTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Akari Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad TradeSmithThe A.I. story nobody is telling you (Read ASAP)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...Click here to see Louis' new video for yourself. AKTX Stock Chart for Thursday, May, 2, 2024 AKTX Chart by TradingView Akari Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/02/2024$1.70$1.47-13.53%$1.87$1.4338,277 shs$11.64 million05/01/2024$1.54$1.70+10.39%$1.85$1.51162,994 shs$13.46 million04/30/2024$1.28$1.54+20.32%$1.54$1.2939,334 shs$12.20 million04/29/2024$1.19$1.28+8.01%$1.35$1.1822,004 shs$10.14 million04/26/2024$1.19$1.18-0.84%$1.20$1.1710,002 shs$9.35 million04/25/2024$1.19$1.19$1.20$1.173,902 shs$9.43 million Get the Latest News and Ratings for AKTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Akari Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/24/2024$1.22$1.19-2.46%$1.21$1.177,532 shs$9.43 million04/23/2024$1.18$1.22+3.39%$1.24$1.134,786 shs$9.66 million04/22/2024$1.17$1.18+1.18%$1.22$1.1313,919 shs$9.35 million04/19/2024$1.21$1.17-3.62%$1.20$1.083,740 shs$9.24 million04/18/2024$1.19$1.21+1.68%$1.23$1.118,776 shs$9.58 million04/17/2024$1.16$1.19+2.59%$1.21$1.107,932 shs$9.43 million04/16/2024$1.20$1.16-3.33%$1.25$1.1414,524 shs$9.19 million04/15/2024$1.21$1.20-0.83%$1.27$1.209,109 shs$9.51 million04/12/2024$1.18$1.21+2.54%$1.27$1.2128,156 shs$6.84 million04/11/2024$1.30$1.18-9.23%$1.32$1.1237,351 shs$6.67 million04/10/2024$1.30$1.30$1.30$1.1911,273 shs$7.43 million04/09/2024$1.43$1.30-9.09%$1.49$1.307,481 shs$7.35 million04/08/2024$1.41$1.43+1.42%$1.50$1.205,390 shs$8.08 million04/05/2024$1.44$1.43-0.69%$1.52$1.413,798 shs$8.08 million04/04/2024$1.55$1.44-7.10%$1.58$1.4327,921 shs$8.14 million04/03/2024$1.51$1.55+2.65%$1.58$1.5114,093 shs$8.76 million04/02/2024$1.51$1.51$1.56$1.518,244 shs$8.53 million04/01/2024$1.87$1.51-19.03%$1.85$1.50110,540 shs$8.53 million03/29/2024$1.85$1.87+0.81%$1.90$1.7213,382 shs$10.54 million03/28/2024$1.80$1.85+2.78%$1.90$1.7213,382 shs$10.45 million03/27/2024$1.86$1.80-3.23%$1.90$1.7034,767 shs$10.17 million03/26/2024$1.89$1.86-1.59%$1.89$1.8113,901 shs$10.51 million03/25/2024$1.81$1.89+4.42%$1.89$1.872,448 shs$10.68 million03/22/2024$1.83$1.82-0.55%$1.89$1.7459,394 shs$10.28 million03/21/2024$1.90$1.83-3.67%$1.90$1.6629,037 shs$10.34 million03/20/2024$1.91$1.90-0.53%$1.92$1.765,653 shs$10.73 million03/19/2024$2.00$1.91-4.50%$1.98$1.852,721 shs$10.79 million03/18/2024$1.97$2.00+1.52%$2.00$1.971,859 shs$11.30 million03/15/2024$2.04$1.97-3.43%$2.03$1.955,450 shs$11.13 million03/14/2024$2.15$2.04-5.12%$2.16$1.9512,097 shs$11.53 million03/13/2024$2.14$2.15+0.47%$2.20$2.0514,673 shs$12.15 million03/12/2024$2.15$2.14-0.47%$2.29$2.1416,732 shs$12.09 million03/11/2024$2.14$2.15+0.47%$2.17$2.146,415 shs$12.15 million03/08/2024$2.22$2.14-3.60%$2.25$2.117,953 shs$12.09 millionGold Mania (Ad)Former Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).See his free reveal right here.03/07/2024$2.20$2.22+0.91%$2.25$2.181,678 shs$12.54 million03/06/2024$2.26$2.20-2.66%$2.37$2.186,035 shs$12.43 million03/05/2024$2.25$2.26+0.45%$2.40$2.2315,034 shs$12.77 million03/04/2024$2.28$2.25-1.32%$2.44$2.2023,574 shs$12.71 million03/01/2024$2.21$2.28+3.17%$2.34$2.219,264 shs$12.88 million02/29/2024$2.22$2.21-0.45%$2.37$2.186,787 shs$12.49 million02/28/2024$2.30$2.22-3.48%$2.33$2.1514,434 shs$12.54 million02/27/2024$2.24$2.30+2.68%$2.40$2.292,199 shs$13.00 million02/26/2024$2.34$2.24-4.27%$2.37$2.201,483 shs$12.66 million02/23/2024$2.24$2.17-3.13%$2.34$2.121,818 shs$12.26 million02/22/2024$2.38$2.24-5.88%$2.31$2.246,053 shs$12.66 million02/21/2024$2.39$2.38-0.42%$2.40$2.323,145 shs$13.45 million02/20/2024$2.24$2.39+6.70%$2.39$2.32969 shs$13.50 million02/19/2024$2.24$2.24$2.30$2.167,500 shs$12.66 million02/16/2024$2.38$2.24-5.88%$2.30$2.167,590 shs$12.66 million02/15/2024$2.38$2.38$2.40$2.103,087 shs$13.45 million02/14/2024$2.40$2.38-0.83%$2.39$2.38393 shs$13.45 million02/13/2024$2.40$2.40$2.40$2.4070 shs$13.56 million02/12/2024$2.40$2.40$2.40$2.287,855 shs$13.56 million02/09/2024$2.45$2.50+2.04%$2.50$2.401,652 shs$14.13 million02/08/2024$2.57$2.45-4.67%$2.45$2.32845 shs$13.84 million02/07/2024$2.64$2.57-2.47%$2.57$2.57917 shs$14.52 million02/06/2024$2.51$2.64+4.99%$2.64$2.414,535 shs$14.89 million02/05/2024$2.49$2.51+0.80%$2.51$2.259,608 shs$14.18 million02/02/2024$2.51$2.49-0.80%$2.74$2.4424,641 shs$14.08 million02/01/2024$2.53$2.51-0.79%$2.61$2.51389 shs$14.18 million Related Companies: Aeterna Zentaris Stock Chart Alterity Therapeutics Stock Chart Elevai Labs Stock Chart Moleculin Biotech Stock Chart Guardion Health Sciences Stock Chart Galera Therapeutics Stock Chart Eterna Therapeutics Stock Chart NuCana Stock Chart Molecular Templates Stock Chart Virios Therapeutics Stock Chart Receive AKTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Akari Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AKTX) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressUrgent Nvidia WarningAltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmithYour bank is lying to you.MyBankTrackerThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingTrump just won 2024Porter & CompanyHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akari Therapeutics, Plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.